Treatment Response Evaluation in Gastrointestinal Stromal Tumor (GIST) Patients

Oslo University Hospital40 enrolled

Overview

The purpose of this study is to compare sensitivity, specificity and accuracy of PET, DW MRI and CT separately and combined for the evaluation of treatment response and progression-free survival in patients with GIST.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Soft Tissue Neoplasms Gastrointestinal Tract

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Metastatic GIST patients suitable for TKI treatment * GIST patients pursuing preoperative neoadjuvant TKI treatment Exclusion Criteria: * Patients with contraindications to MRI and/or TKI treatment. For patients with renal failure, CT without intravenous contrast will be performed according to clinical practice. * Patients who do not sign the consent paper for any reason or do not accept the study premises or patients who wish to withdraw for any reason during the study

Locations (1)

Oslo University Hosptal

Oslo, Norway

Outcomes

Primary Outcomes

Radiologic-pathologic correlation

Time frame: 2 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.